Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414379 | SCV000492086 | uncertain significance | not specified | 2016-12-05 | criteria provided, single submitter | clinical testing | The FDG4 variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.-93+1 G>A variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Several in-silico splice prediction models predict that c.-93+1 G>A may destroy a cryptic donor site which may supplant the natural donor site for intron 2 and lead to abnormal gene splicing. However, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |